Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Prelude Therapeutics Inc
| Metric | Prelude Therapeutics Inc PRLDHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $12M |
| Net income (latest) | −$99M |
| Operating margin | −861.3% |
| Net margin | −819.6% |
| Return on equity | −145.0% |
| Return on assets | −70.4% |
| Return on capital (ROCE) | −118.4% |
| Debt / equity | 1.06× |
| Revenue growth (YoY) | 73.4% |
| Altman Z″ (distress) | -17.29 |
| Accruals / assets | −30.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.